.png)
Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and over 80 preclinical drug candidates delivered to our clients. Backed by thousands of scientists, our comprehensive, integrated portfolio employs the latest technology to provide small molecule screening, high throughput screening, chemistry, biology, and pharmacology services that support clients from hit identification all the way through to IND.